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Summary
Background: Studies in Drosophila have taught us
a great deal about how animals regulate the immediate
innate immune response, but we still know little about
how infections cause pathology. Here, we examine the
pathogenesis associated with Mycobacterium marinum
infection in the fly. M. marinum is closely related to
M. tuberculosis, which causes tuberculosis in people.
Results: A microarray analysis showed that metabolism
is profoundly affected in M. marinum-infected flies. A
genetic screen identified foxo mutants as slower-dying
after infection than wild-type flies. FOXO activity is in-
hibited by the insulin effector kinase Akt; we show that
Akt activation is systemically reduced as a result of
M.marinum infection. Finally, we show that flies infected
with Mycobacterium marinum undergo a process like
wasting: They progressively lose metabolic stores, in
the form of fat and glycogen. They also become hyper-
glycemic. In contrast, foxo mutants exhibit less wasting.
Conclusions: In people, many infections—including
tuberculosis—can cause wasting, much as we see in
Drosophila. Our study is the first examination of the met-
abolic consequences of infection in a genetically tracta-
ble invertebrate and gives insight into the metabolic
consequences of mycobacterial infection, implicating
impaired insulin signaling as a key mediator of these
events. These results suggest that the fly can be used
to study more than the immediate innate immune re-
sponse to infection; it can also be used to understand
the physiological consequences of infection and the im-
mune response.
Introduction
The humoral immune response of Drosophila mela-
nogaster has been intensely studied in recent years
[1]. As a result, we know a great deal about the mecha-
nisms by which systemic immune responses are acti-
vated in this model organism but much less about infec-
tion-induced pathogenesis and the consequences of
immune activation. Though the immune response is
necessary to fight infection, immunity itself often has
pathological consequences for the host organism. Im-
mune-induced changes to physiology, such as ca-
chexia, fibrosis, and fever, are typically the proximal
causes of pathology and death resulting from infection
in people. For example, most tuberculosis morbidity
*Correspondence: dschneider@stanford.eduand mortality result either from inflammatory damage
to the lung or from wasting; both of these effects are
consequences of persistent immune activation [2–4].
In this work, we examine the mechanisms by which
Mycobacterium marinum kills Drosophila. M. marinum
is a close relative ofM. tuberculosis, the causative agent
of tuberculosis [5];M.marinum itself causes a tuberculo-
sis-like disease in fish and frogs and peripheral granulo-
matous disease in humans [6, 7]. We have shown previ-
ously that the early stages of M.marinum infection in the
fly resemble the early stages of tuberculosis, with bacte-
ria localized within phagocytes where they then proceed
to proliferate [8]. Eventually, the bacteria escape by an
unknown mechanism, only to be once again phagocy-
tosed. After a period of several days, the infection un-
dergoes a transition and the bacteria begin to grow
freely both outside and inside host cells. The cause of
this transition is unclear. There is no sign of formation
of anything like a granuloma in the fly; rather, the disease
seems to pass directly from a stage analogous to very
early tuberculosis to one reminiscent of miliary tubercu-
losis, leading inevitably to death. The causes of death in
this model are the focus of this work.
Here, we show that the bacterial pathogen Mycobac-
terium marinum causes a progressive loss of energy re-
serves in Drosophila melanogaster. This loss is accom-
panied by hyperglycemia and is induced partly by the
transcription factor FOXO. A marked reduction in sys-
temic Akt activation facilitates FOXO activity in M. mar-
inum-infected flies; this reduction in Akt activity is also
visible as a reduction in an inhibitory phosphorylation
of Gsk-3. The signaling pathway between the insulin
receptor and Akt remains intact in infected animals, be-
cause Akt phosphorylation can be restored by adminis-
tration of low doses of insulin. Taken together, our data
suggest a model in which mycobacterial infection
causes a systemic reduction in Akt activation, either
by reducing the level of circulating insulin or by increas-
ing the turnover of activated Akt. This results in exces-
sive Gsk-3 and FOXO activity, which causes the pro-
gressive loss of energy stores. The loss of energy
stores has pathological effects.
Results
Mycobacterial Infection Induces Widespread
Alterations in Expression of Genes Involved
in Energy Storage
To identify host genes affected by infection with
M.marinum, we examined host-gene expression at sev-
eral points during disease progression by using oligonu-
cleotide microarrays (see Figure S1 in the Supplemental
Data available online). We chose a large initial inoculum
and a high culture temperature for this experiment
(5000 cfu at 29C) for two reasons: First, we wanted
a rapid, highly synchronized course of infection; and
second, we wanted to be able to choose an early time
point (24 hr) at which all, or nearly all, host phagocytes
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1978Table 1. Expression Levels and P Values for Enzymes of Glycogen Synthesis and Degradation and Triglyceride Synthesis
Gene Probe Activity Exp. Ratio log2(PBS/Mm) p Value
Enzymes of glycogen synthesis and degradation
Pgm 154763_at phosphoglucose mutase 0.674 20.569 0.015
CG4347 153782_at UDP-glucose pyrophosphorylase 0.655 20.61 0.052
CG6904 141226_at glycogen synthase 0.652 20.616 0.043
CG33138 153504_at glycogen branching enzyme 0.708 20.498 0.013
CG9485 154730_at glycogen debranching enzyme 0.53 20.916 0.002
GlyP 154262_at glycogen phosphorylase 0.644 20.636 0.013
Enzymes of triglyceride synthesis
CG31305 155150_at mitochondrial citrate transporter 0.795 20.33 0.036
ATPCL 143912_at ATP citrate lyase 0.743 20.428 0.129
CG11198 152407_at acetyl-CoA carboxylase 0.631 20.664 0.001
CG3523 152126_at fatty acid synthase 0.745 20.424 0.016
v(2)k05816 151887_at fatty acid synthase 1.007 0.01 0.964
CG7995 152740_at glycerol kinase 0.652 20.617 0.019
Gpdh 153347_at glycerol-3-phosphate dehydrogenase 0.731 20.451 0
CG5508 152088_at glycerol-3-phosphate acyltransferase 0.738 20.438 0.004
CG4729 142408_at 1-acylglycerol-3-phosphate O-acyltransferase 0.685 20.546 0.006
CG4753 142407_at 1-acylglycerol-3-phosphate O-acyltransferase 0.776 20.366 0.075
CG11426 149233_at phosphatidic acid phosphatase type 2 0.992 20.012 0.911
CG11425 149234_at phosphatidic acid phosphatase type 2 1.867 0.901 0.003
wun 142143_at phosphatidic acid phosphatase type 2 1.094 0.129 0.009
mdy 154661_at diacylglycerol acyltransferase type 1 0.712 20.49 0.057
mdy 146381_at diacylglycerol acyltransferase type 1 0.538 20.894 0.094
Expression levels of enzymes of glycogen synthesis and degradation and of triglyceride synthesis from microarray analysis. Italicized rows show
significant downregulation. midway (mdy) is counted as significant because this gene is represented by two probes, both of which were down-
regulated and each of which was close to the p < 0.05 cutoff. p values are from Student’s t test. Only probes scored as ‘‘present’’ in all or most
samples are shown. In total, 262 probes met these criteria.would be infected, but there would be few or no extra-
cellular bacteria. We collected samples at 24, 72, and
96 hr after infection; at 120 hr, all the remaining flies
had been killed by the infection, as expected for this
dose and culture temperature. (The 24 hr data will not
be discussed here, but display none of the expression
changes we will describe for the later time points.) The
72 hr data are the most informative regarding disease
pathogenesis: This time point precedes the onset of vis-
ible disease but still shows changes in gene expression
dramatically different from those seen on previous Dro-
sophila immune arrays. At 72 hr, we began to see some
signs of Toll- or imd-pathway activation; in keeping with
our previous work, these changes were not seen at the
24 hr time point and were mild (e.g.,Drosocin and cactus
are induced 2.1-fold and 2.2-fold, respectively, relative
to the PBS-injected control). We do not know why there
is so little transcriptional response by the canonical im-
munity genes; what induction we see of these genes
may be a result of accumulation of bacterial products
ultimately reaching the point of activating pattern-rec-
ognition receptors, or it may be a consequence of a dan-
ger-type response. The presence of mycobacterial RNA
has no obvious confounding effects on the microarray
analysis, though crosstalk between individual bacterial
and host transcripts cannot be excluded. The complete
table of genes repressed or induced at 72 hr is included
as Table S1.
At the 72 hr point, we observed significant reductions
in the mRNA levels of several key enzymes of energy
metabolism and storage. Many of the regulated en-
zymes were involved in energy storage; this was con-
firmed by analysis of the set of genes reduced at 72 hrfor overrepresented Gene Ontology classifications [9]
(Table S2). The enzymes of glycogen synthesis and deg-
radation are uniformly reduced in level (Table 1,
Figure S1, and Table S3). Nearly all of the enzymes of tri-
glyceride synthesis are reduced; the most prominent ex-
ceptions, the phosphatidic acid phosphatases, also
have roles in signal transduction and would not neces-
sarily be coregulated with the other enzymes in this
pathway (Table 1, Figure S1, and Table S3). The levels
of some metabolic enzymes are increased; these are
typically catabolic activities. As might be expected, en-
zymes with reduced expression at 72 hr are generally
further reduced at the 96 hr time point, and several ana-
bolic activities that had missed the cutoff for regulation
at 72 hr are strongly regulated at 96 hr, such as UDP-
glucose pyrophosphorylase and ATP-citrate lyase
(Table S3).
In order both to validate our microarray findings and to
examine some of the observed changes in more detail,
we analyzed the expression of several of the regulated
genes by RT-PCR. This experiment was done at a lower
bacterial dose (500 colony-forming units) and a lower
temperature (25) than the microarray experiment to
slow the rate of death from infection in hopes of picking
out finer details in the time course. We examined ex-
pression of glycogen phosphorylase (GlyP), glycogen
synthase (CG6904), hormone-sensitive lipase (CG11055),
diacylglycerol acyltransferase (mdy), and acetyl-CoA
carboxylase (CG11198) (Figure 1). All of these activities
except for hormone-sensitive lipase had been regulated
at the 72 hr time point on our microarrays. In this case,
the onset of regulation of the anabolic activities
(CG6904, mdy, and CG11198) significantly preceded
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and CG11055) (Figure 1). We do not know the origin of
this difference between the microarray data and the
RT-PCR data; it may be due to the different dose and
temperature, differences in the food provided to the flies
between the two experiments, or variation in expression
between individuals (as suggested by the size of the er-
ror bars in Figure 1, variation in expression was often
significant). In addition to the activities shown, we also
confirmed that pyruvate carboxylase (CG1516) and
shifted (shf) showed the expected regulation (data not
shown).
In order to determine whether these changes in meta-
bolic activities were also seen in infections ofDrosophila
with other pathogens, we compared our data with the
available microarray studies of flies infected with Beau-
veria bassiana, an entomopathogenic fungus [10]. The
Beauveria experiments had time points of 12, 24, 48,
and 96 hr after infection; because it was not obvious
which time points were most comparable with our 72
and 96 hr time points, we examined all four sets, focus-
ing specifically on the core genes of glycogen synthesis
and degradation and triglyceride synthesis (those genes
in the first two categories of Table S3). We had found
that 12/25 of these genes were downregulated at the
72 hr time point on our arrays, and 14/25 were downre-
gulated at the 96 hr time point (that is, the expression
ratio was 0.76 or less, with a p value of less than 0.05)
Figure 1. mRNA Levels of Genes Involved in Energy Storage Are
Reduced in Infected Drosophila
Top: quantitative RT-PCR analysis of expression of GlyP, CG6904,
CG11055, mdy, and CG11198 on the last 3 days of infection. The
dose used was 500 colony-forming units, and flies were cultured
at 25C after infection.
Bottom: survival of flies infected alongside those used for RT-PCR.
The red arrowheads indicate the time points to which the rest of the
figure refers. This survival curve is typical for the dose, temperature,
and genotype used.(Table S3). With Beauveria, 3/25 were downregulated
at 12 hr, 2/25 at 24 hr, 0/25 at 48 hr, and 6/25 at 96 hr
(with the same fold cutoff but without considering
p values, because the 48 and 96 hr time points were rep-
resented by only two arrays each) [10]. Another study
examined gene expression in flies infected with the
pathogenic Pseudomonas aeruginosa strain PA14 in
comparison with the nonpathogenic strain CF5 [11]. In
this case, none of the 25 metabolic genes we examined
were identified as being regulated. It thus appears that
whatever changes accompany pathogenesis in Beauve-
ria- or Pseudomonas-infected animals are not repre-
sented by the same metabolic transcriptional signature.
foxo Mutants Die More Slowly Than Wild-Type Flies
but Show No Change in Bacterial Numbers
In parallel with the microarray analysis, we performed
a small genetic screen for Drosophila mutants that die
more quickly or more slowly than wild-type flies when in-
fected with M. marinum. This screen was performed on
homozygous-viable transposon mutants available from
the Bloomington Drosophila Stock Center. Of 1800 mu-
tant lines screened, approximately 15 are distinctly
short-lived and 21 long-lived when infected, although
the complete analysis of the results from this screen
are incomplete (data not shown).
One long-lived mutant carries a transposon insertion,
BG01018, roughly 130 nucleotides upstream of the tran-
scriptional start site of the foxo gene, resulting in a mild
loss of function. foxo encodes the soleDrosophila mem-
ber of the O class forkhead transcription factor (FoxO)
family [12–14]. In mice, Foxo1 is an important effector
of the insulin-deprived state and is partially responsible
for the hyperglycemia and in hepatic-gluconeogenesis
defects characteristic of diabetes [15–17]. Because of
the profound metabolic effects seen in our microarray,
we decided to further examine the role of foxo inM.mar-
inum infection. Our original foxo allele, foxoBG01018, has
a mild, though statistically significant, effect on survival
after infection (foxoBG01018/foxo21 animals display
a 4.8% improvement in median survival; 174 hr versus
166 hr). The null alleles foxo21 and foxo25 [16] and the
foxo deficiency Df(3R)ED5634 have a stronger effect
(14% improvement in median survival; 190 hr versus
166 hr) (Figure 2A). foxoBG01018/foxo21 and foxoBG01018/
foxo25 animals are identical with regard to disease kinet-
ics (data not shown).
foxo mutants might die more slowly when infected
with M. marinum because they are less permissive of
bacterial growth. To test this hypothesis, we developed
an RT-PCR assay to detect the mycobacterial gene
pyrG, which encodes CTP synthase. This gene was cho-
sen because a previous screen for M. marinum genes
expressed in granulomas had found that pyrG was ex-
pressed strongly and uniformly in broth, macrophages,
and frog granulomas, making pyrG a good target to
measure bacterial number [18]. On the basis of this as-
say, the number of bacteria in either foxo mutant was
not significantly different from wild-type animals for
the second half of disease at the high bacterial doses
used in this work (Figure 2B), indicating that changes
in bacterial number do not underlie the observed
changes in death kinetics.
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1980Figure 2. foxo Mutants Die More Slowly from
M. marinum Infection but Contain the Same
Number of Bacteria
(A) Survival curve for wild-type (black lines),
foxoBG01018/foxo21 (green lines), foxo21/
foxo25 (blue lines), and foxo21/Df(3R)ED5634
(red lines) animals. The dose used was 500
colony-forming units, and flies were cultured
at 25C after infection. The thick lines indicate
survival of M. marinum-infected animals; fine
lines are PBS-injected controls. The shaded
areas indicate 95% confidence intervals for
survival of infected animals. Number of
events (i.e., number of animals observed to
die) for each genotype are as follows: wild-
type, 163; foxoBG01018/foxo21, 136; foxo21/
foxo25, 205; and foxo21/Df(3R)ED5634, 155.
These results are pooled from four different
experiments; all four experiments gave simi-
lar results.
(B) Quantification of M. marinum load by
quantitative RT-PCR. Error bars indicate
one standard deviation.Insulin Signaling via Akt Is Reduced in M. marinum-
Infected Flies
The fact that we had observed widespread reductions in
transcripts involved in energy storage, combined with
the effects resulting from the foxo mutation, suggested
that loss of insulin signaling might underlie some as-
pects of disease pathogenesis (see below). Insulin in-
hibits foxo activity via Akt, so we examined systemic
Akt activation in infected flies. Full Akt activity requires
the TOR-dependent phosphorylation of a C-terminal hy-
drophobic motif (serine 505 in Drosophila) [19–21], al-
lowing us to measure systemic Akt activation by mea-
suring levels of serine-505-phosphorylated Akt protein.
Levels of the 60 kDa isoform of phospho-Akt are pro-
gressively reduced in infected animals during the sec-
ond half of the disease course (Figure 3B). There is no
consistent reduction in total Akt protein, and phosphor-
ylation of the larger isoform is variably affected for rea-
sons we do not understand (compare Figures 3B and
3C). To determine whether this reduction in phosphory-
lation reflects a difference in steady-state activity, we
examined phosphorylation of glycogen synthase kinase
3 (Gsk-3) on serine 9; this site is a direct target of Akt
[22]. The reduction in phospho-Akt is correlated with
a reduction in phospho-Gsk-3, confirming that Akt activ-
ity is reduced in sick animals; in the case of Gsk-3, both
isoforms were affected (Figure 3C). The same result was
observed for Thr398 phosphorylation of p70 s6 kinase
(data not shown), which is also Akt dependent but is
not a direct target [23, 24].
The Disruption of Signaling via Akt Is Not Like
that Seen in Type-2 Diabetics
Decreased levels of active Akt could result from de-
creased secretion of insulin or from insulin resistance.
Acquired insulin resistance (as opposed to insulin resis-
tance in insulin-receptor knockout mice, for example) is
usually ascribed to a block in the insulin signalingpathway between the insulin receptor and Akt activation
[25–29]; this is believed to underlie disease in type-2 di-
abetics. To test whether M. marinum-infected flies are
insulin resistant in a way that mimics type-2 diabetes,
we injected infected flies with recombinant human insu-
lin and determined Akt activation levels by western blot
(Figure 3D). The basal level of Akt activation is much
lower in infected animals than in controls, but injection
of even low doses of insulin induces phosphorylation
of Akt in sick animals, confirming that the pathway be-
tween the insulin receptor and Akt is intact (Figure 3D).
(Insulin injection does not change the time to death of in-
fected animals; this may be because the effects of a sin-
gle insulin injection do not persist, or because the posi-
tive effects of the injection are confounded by the
negative consequences of wounding.) It is difficult to as-
say circulating insulin levels directly in adult flies. How-
ever, this result suggests that low Akt activation during
infection is due to a reduction in the quantity of circulat-
ing insulin, degradation of activated Akt, reduction in
some other Akt-activating signal, or a combination of
all of these, rather than to insulin resistance as in type-
2 diabetics.
Activation of the Drosophila immune response can re-
sult in activation of the stress-activated MAP kinase JNK
[30]. JNK activation can also disrupt insulin signaling
[31, 32]. In order to determine whether systemic activa-
tion of JNK was resulting in systemic disruption of Akt
activation, we examined levels of activated JNK in in-
fected flies through the last 3 days of infection. We found
no consistent reduction in systemic JNK activation as
a result of this infection (Figure S2). In further support
of this point, we examined the expression of the JNK tar-
get genes puc,Ance, chic,mys,Appl,w, and cher on our
arrays [33, 34]. None of these genes showed significant
regulation at 72 hr (Table S3). It is possible that JNK is
being activated specifically in insulin-producing cells
and disrupting insulin production, as has been
FOXO, Akt, and Infection-Induced Wasting
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cate that JNK activation in insulin-responding tissues
does not cause the infection-dependent changes we
observe in Akt activation.
Figure 3. Akt Activity Is Reduced in Infected Flies
(A) Survival curve for flies infected alongside those used for blot
shown in (B) and also for analysis in Figure 4. Black line is PBS in-
jected; gray line is M. marinum injected. The lighter-gray areas are
95% confidence intervals. The dose used was 500 colony-forming
units, and flies were cultured at 25C after infection. This survival
curve is typical for the dose, temperature, and genotype used.
(B) Systemic levels of serine-505-phosphorylated and total Akt pro-
tein were measured by western blot. Progressive reduction of acti-
vated 60 kDa Akt is correlated with the appearance of a 30 kDa
form, likely a cleavage product, which is visible as early as 2 days af-
ter infection. The 30 kDa cleavage product may reflect enhanced
degradation of activated Akt in M. marinum-infected animals.
(C) Systemic levels of serine-9-phosphorylated and total Gsk-3 pro-
tein measured by western blot. (Gsk-3 in the fly has at least four pro-
tein isoforms; those at 59 and 81 kilodaltons are visible on this blot).
The level of Akt-phosphorylated Gsk-3 is reduced in concert with the
reduction in serine-505 phosphorylation of Akt.
(D) Mock-infected or M. marinum-infected animals were injected
with 25 nl HBSS to which no insulin (0), 32 pg (L), or 160 pg (H) human
insulin had been added. Ten minutes later, flies were homogenized,
and their Akt phosphorylation state was measured by western blot.
The doses (32 and 160 pg/fly) were chosen because 160 pg/fly was
the smallest dose that consistently caused a visible increase in Akt
phosphorylation in uninfected animals.M. marinum-Infected Flies Progressively Lose
Glycogen and Fat and Are Hyperglycemic
The loss of Akt activation and the changes in metabolic
transcript levels both suggested that energy storage
would be changed in infected animals. We measured
the glycogen, triglyceride, and glucose content of in-
fected flies over the course of disease. (We have de-
tected no significant quantity of trehalose in our flies, un-
like other investigators [35, 36]; this discrepancy may
reflect differences in diet or genetic background.) We
found that the final stages of infection are characterized
by a progressive loss of glycogen and triglyceride (Fig-
ure 4). Wasting of glycogen and fat is associated with
an increase in free glucose (Figure 4). The changes we
see in infected flies are not simply the result of dis-
ease-induced anorexia; in starved animals, free glucose
is reduced rather than elevated (Figure S3). Further-
more, the expression changes we observed in our mi-
croarray analysis are dissimilar to those seen in starved
adult Drosophila (Table S4) [37].
The Extent of Wasting Is Reduced in Hypomorphic
foxo Mutants
We had observed that foxomutant flies died more slowly
from the infection despite carrying approximately the
same number of bacteria as wild-type flies. We hypoth-
esized that if these flies are not more effective in fighting
infection, foxo must mediate some of the pathogenic ef-
fects of infection. Because Akt is a direct inhibitor of
FOXO and because our data implicate loss of active
Akt in wasting, we further hypothesized that infected
foxo mutants should maintain energy stores longer
than wild-type flies [13, 14, 38]. To test this hypothesis,
we examined the level of triglyceride, glycogen, and glu-
cose in these animals on the last 3 days of infection. The
rate of glycogen loss is slowed in foxoBG01018/foxo21 flies
(Figure 5); this is confirmed by ANCOVA (p = 0.008). The
mild apparent reduction in rate of triglyceride loss is not
statistically significant, and hyperglycemia is unaffected
in foxoBG01018/foxo21 flies (Figure 5). These data confirm
the role of foxo in mediating M. marinum-induced wast-
ing. We attempted to examine wasting in foxo null mu-
tants, but found that levels of glycogen, triglyceride,
and glucose in these animals was profoundly variable,
even in the unmolested state (for example, the standard
deviation of glycogen readings for these animals was
more than two-thirds of the mean); this, combined with
the difficulty of getting these animals in large numbers,
made meaningful analysis impossible.
We also wished to know whether foxo was responsi-
ble for the transcriptional changes that had first moti-
vated us to examine the metabolic state of M. mari-
num-infected flies. The fact that changes in Akt activity
precede the changes we had previously observed in
mRNA levels (compare time points between Figure 1B
and Figure 3) suggested that the transcriptional changes
might be secondary to the observed changes in Akt
phosphorylation. We examined the expression of glyco-
gen synthase (CG6904), diacylglycerol acyltransferase
(mdy), and acetyl-CoA carboxylase (CG11198) in foxo
mutants and found that expression of all three genes
was partially or completely rescued in these animals on
the last 2 days of infection (Figure 5B), indicating that
these transcriptional changes are partly the result of
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1982Figure 4. M. marinum-Infected Drosophila Progressively Lose Fat and Glycogen and Become Hyperglycemic
Glycogen, triglyceride, and glucose levels during the later days of the infection; dose, culture temperature, and survival are as shown in Figure 3A.
The heavy line is the median reading, the box extends to the first and third quartiles of the data, and the whiskers indicate the most distant data
point that is no more than 2.5 times the interquartile distance from the median; more distant points are indicated. Gray bars indicate readings
from M. marinum-infected flies, and white bars indicate readings from M. smegmatis-infected controls. The rates of glycogen and triglyceride
loss in M.marinum-infected animals are significantly different from those in M. smegmatis-infected animals by ANCOVA (p values for both slope
and intercept are different: glycogen, p = 0.005; triglyceride, p = 0.0004). There is significantly more free glucose in M.marinum-infected animals
than in M. smegmatis-infected animals at day 6 (p = 0.0002, Student’s t test); because of the variability of the data, the difference at day 7 is only
marginally significant (p = 0.037). The number of flies at each time point is as follows:M. smegmatis-infected, 21 flies/time point, except for day 7,
where n = 15; M. marinum-infected, glycogen and triglyceride measurements, n = 75 on day 4, n = 120 on days 5 and 6, and n = 75 on day 7;
M. marinum-infected, glucose measurements, n = 66 on day 4, n = 81 on days 5 and 6, and n = 39 on day 7.excess foxo activity. These animals lose triglyceride at
nearly the same rate as wild-type animals (Figure 5A);
the fact that expression of the two primary rate-limitingenzymes of triglyceride synthesis (diacylglycerol acyl-
transferase and acetyl-CoA carboxylase) is mostly res-
cued in these mutants indicates that these transcriptionalFigure 5. foxo Mutants Exhibit Reduced Gycogen Loss and Smaller Changes in Levels of Anabolic Transcripts
(A) Levels of glycogen, triglyceride, and glucose in wild-type and foxoBG01018/foxo21 animals. Plot parameters as described for Figure 4; gray bars
are M. marinum-infected wild-type animals, and white bars are M. marinum-infected foxoBG01018/foxo21 mutants. The difference in the rate of
glycogen loss is statistically significant (p = 0.008 for slope and intercept different by ANCOVA). These flies were infected and cultured alongside
one of the four sets used for the survival analysis shown in Figure 2. The data for wild-type flies are the same as those in Figure 4 and are repro-
duced here to facilitate comparison.
(B) Levels of CG6904, mdy, and CG11198 compared between wild-type and foxoBG01018/foxo21 flies on the last 2 days of life. The data for wild-
type flies are the same as those in Figure 1 and are reproduced here to facilitate comparison (these experiments were done in parallel). Each
experiment was done in triplicate.
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1983changes are useful as an indicator of physiological state
but are probably not the primary cause of these physio-
logical changes.
Discussion
In this work, we have shown that flies infected with
M. marinum undergo a process like wasting. This wast-
ing response is in part the consequence of systemic fail-
ure of Akt activation and consequent activation of the
transcription factor FOXO, resulting in a diabetes-like
state. The observed failure of Akt activation is not
caused by traditional insulin resistance mechanisms.
Our data suggest that mycobacterial infection causes
a systemic reduction in Akt activation, either by reduc-
ing the level of circulating insulin or by increasing the
turnover of activated Akt, or both. This results in exces-
sive Gsk-3 and FOXO activity, which causes the pro-
gressive loss of energy stores. This model is dia-
grammed in Figure 6. On the basis of our data and that
of others, we argue that the impaired insulin signaling
we see in M. marinum-infected Drosophila is likely to
represent a common response to many infections in
many hosts, including humans, and moreover is likely
a significant cause of disease morbidity.
foxo and the Mechanisms of Death from Infection
As we have shown, foxo mutants are longer-lived when
infected with M.marinum. This makes an intriguing con-
trast with the observation that flies overexpressing foxo
are longer-lived than wild-type flies when uninfected [39,
40]. Moreover, foxo mutant flies die more rapidly than
wild-type flies under conditions of oxidative stress
[12]. These observations suggest that death from old
Figure 6. Model of Metabolic Akt Signaling in Healthy and M. mari-
num-Infected Drosophila
Our data suggest two potential models: In the first, sick flies have
lower levels of circulating insulin-like peptides; in the second, sick
flies have increased degradation of activated Akt. These two possi-
bilities are not mutually exclusive. InR is the Drosophila insulin
receptor.age or oxidative stress is mechanistically different
from death from M. marinum infection.
The Role of Insulin-like Signals as Metabolic
Regulators in Drosophila
In order to put our data into proper context, it is impor-
tant to understand the complex role of insulin-like sig-
nals in the control of metabolism in adult Drosophila.
The situation in mammals, and also in Drosophila lar-
vae, seems clear. In humans, insulin is among the most
important anabolic signals, and it is also a satiety signal:
type-1 diabetics (who progressively lose the insulin-
producing cells of the pancreas) exhibit increases in ap-
petite and consequently in food intake, even as they are
progressively losing body mass. In fly larvae, insulin-
like peptides (ILPs) appear to play a role roughly analo-
gous to the metabolic role seen in humans: Larvae in
which the insulin receptor (InR) or PI3 kinase (PI3K) are
overexpressed accumulate excessive levels of fat and
show reduced feeding [41]. Conversely, larvae that
lack ILP-producing cells (IPCs) in the brain become
hyperglycemic [36].
In adult flies, the metabolic role of ILPs has appeared
more complex. The loss of ILP signaling via IPC ablation
or loss-of-function mutations in chico (the fly homolog of
mammalian IRS proteins) or InR results in increased tri-
glyceride and glycogen storage—although, in the case
of IPC ablation, this increase in energy stores is still ac-
companied by hyperglycemia [35, 42, 43]. More recent
work with a temperature-sensitive InR allele showed
that the critical period for the increase in metabolic stor-
age is during pupariation, indicating that the storage ef-
fect should be regarded as a developmental defect
rather than a physiological one [44]. Our work is the first
examination of the results of insulin inhibition in wild-
type adult flies without developmental perturbation.
We suggest that the insulin signaling pathway acts in
adult flies to drive glucose uptake and energy storage
in a manner analogous to its action in mammals and lar-
val Drosophila.
Ecological Immunology and Implications for Human
Disease
Immune responses pose significant costs for the host
[45–48]. One hypothesis suggests that the primary cost
of immune responses is energetic: that metabolic energy
used by the immune system is being taken from other im-
portant systems. This has been easiest to observe in
cases where animals are placed under energy con-
straints and then forced to raise an immune response:
In these situations, the induced immune responses
have easily observable deleterious effects on other
physiological processes [47, 49]. Conversely, this cost
is also visible as immunosuppression in animals that
are carrying out other energy-intensive activities [50, 51].
These observations suggest that there should be
mechanisms for direct control of energy allocation to
the immune response. Our data indicate that Akt and
Foxo form an important component in this regulation.
We speculate that the systemic disruption of insulin sig-
naling may be a mechanism by which insects reduce en-
ergy allocation to nonimmune tissues; moreover, we
speculate that a similar mechanism operates in mam-
mals. The clinical literature is rich with examples of
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[52]. Tuberculosis and other chronic infections can be
associated with slow wasting of fatty and lean tissues
and glucose intolerance [53, 54]; acute bacteremia
tends to be associated with rapid wasting and full-scale
hyperglycemia [55]. Resting insulin levels are an excel-
lent predictor of survival in septic patients [56], and
aggressive treatment of septic hyperglycemia with ex-
ogenous insulin dramatically increases survival [57].
Wasting alone could be accounted for simply by the en-
ergetic cost of the immune response; however, infec-
tions often cause hyperglycemia as well, suggesting
that systemic changes in metabolic regulation may be
the underlying cause of infection-induced wasting.
That is, wasting may be a pathological consequence of
regulated energy reallocation. In our view, the impres-
sion that energy reallocation leads inevitably to patho-
logical consequences is a product of the fact that clinical
studies focus on those situations where pathogenesis is
occurring.
Other possibilities should not be overlooked: in partic-
ular, the possibility that the metabolic changes we ob-
serve in the fly might be part of a pathogenic strategy
on the part of the bacterium. Organisms living in the cir-
culation can easily double their local glucose concentra-
tion simply by degrading circulating insulin. In this read-
ing, the fact that a wide variety of infections cause
hyperglycemia in mammals would be a result of the
fact that this strategy is such an attractive one for a path-
ogen that it has been selected many times indepen-
dently. However, the apparent connection between
increased levels of proinflammatory cytokines and
cachexia in mammals leads us to believe that infec-
tion-induced wasting is primarily a consequence of the
host response—though one that is ripe for exploitation
by some classes of pathogen.
We suggest that the loss of insulin signaling may be an
important common thread in the pathogenesis of many
infections in many animals; this loss of insulin signaling
may be a consequence of mechanisms of energy reallo-
cation that are helpful in fighting subclinical infections,
but only hasten the death of the host in the context of
pathogens that cannot be eradicated by the immune
response.
Supplemental Data
Supplemental Data include experimental procedures, four figures,
and four tables and are available with this article online at: http://
www.current-biology.com/cgi/content/full/16/20/1977/DC1/.
Acknowledgments
We thank Martin Ju¨nger and Ernst Hafen for foxo mutant flies; Mary
Stewart and Roel Nusse for antibodies; Karen Liu, Michael Galko,
and John ‘‘Six-Guns’’ Wallingford for comments on the manuscript;
and Stan Falkow, Seung Kim, Joe Arron, and the members of the
Schneider lab for helpful discussion. This work was supported by
the National Institutes of Health (RO1 AI053080 and institutional
training grant 5 T32 AI7328-15) and the Irvington Institute for Immu-
nological Research. Monoclonal antibody E7 developed by Michael
Klymkowsky was obtained from the Developmental Studies Hybrid-
oma Bank developed under the auspices of the National Institute of
Child Health and Human Development and maintained by The Uni-
versity of Iowa, Department of Biological Sciences (Iowa City,
Iowa 52242). Author contributions: M.S.D. and D.S.S. conceived
the experiments; M.S.D. performed the experiments; M.S.D. andL.N.P. analyzed the data; and M.S.D., M.S.-H., and D.S.S. wrote
the paper.
Received: April 6, 2006
Revised: August 14, 2006
Accepted: August 15, 2006
Published: October 23, 2006
References
1. Ferrandon, D., Imler, J.L., and Hoffmann, J.A. (2004). Sensing
infection in Drosophila: Toll and beyond. Semin. Immunol. 16,
43–53.
2. Hnizdo, E., Singh, T., and Churchyard, G. (2000). Chronic pulmo-
nary function impairment caused by initial and recurrent pulmo-
nary tuberculosis following treatment. Thorax 55, 32–38.
3. Schwenk, A., and Macallan, D.C. (2000). Tuberculosis, malnutri-
tion and wasting. Curr. Opin. Clin. Nutr. Metab. Care 3, 285–291.
4. Ross, J.J. (2005). Tuberculosis, bronchiectasis, and infertility:
What ailed George Orwell? Clin. Infect. Dis. 41, 1599–1603.
5. Tønjum, T., Welty, D.B., Jantzen, E., and Small, P.L. (1998). Dif-
ferentiation of Mycobacterium ulcerans, M. marinum, and M.
haemophilum: Mapping of their relationships to M. tuberculosis
by fatty acid profile analysis, DNA-DNA hybridization, and 16S
rRNA gene sequence analysis. J. Clin. Microbiol. 36, 918–925.
6. Ramakrishnan, L. (1997). Images in clinical medicine. Mycobac-
terium marinum infection of the hand. N. Engl. J. Med. 337, 612.
7. Ramakrishnan, L., Valdivia, R.H., McKerrow, J.H., and Falkow,
S. (1997). Mycobacterium marinum causes both long-term sub-
clinical infection and acute disease in the leopard frog (Rana
pipiens). Infect. Immun. 65, 767–773.
8. Dionne, M.S., Ghori, N., and Schneider, D.S. (2003). Drosophila
melanogaster is a genetically tractable model host for Mycobac-
terium marinum. Infect. Immun. 71, 3540–3550.
9. Boyle, E.I., Weng, S., Gollub, J., Jin, H., Botstein, D., Cherry,
J.M., and Sherlock, G. (2004). GO:TermFinder—open source
software for accessing Gene Ontology information and finding
significantly enriched Gene Ontology terms associated with
a list of genes. Bioinformatics 20, 3710–3715.
10. De Gregorio, E., Spellman, P.T., Rubin, G.M., and Lemaitre, B.
(2001). Genome-wide analysis of the Drosophila immune re-
sponse by using oligonucleotide microarrays. Proc. Natl.
Acad. Sci. USA 98, 12590–12595.
11. Apidianakis, Y., Mindrinos, M.N., Xiao, W., Lau, G.W., Baldini,
R.L., Davis, R.W., and Rahme, L.G. (2005). Profiling early infec-
tion responses: Pseudomonas aeruginosa eludes host defenses
by suppressing antimicrobial peptide gene expression. Proc.
Natl. Acad. Sci. USA 102, 2573–2578.
12. Ju¨nger, M.A., Rintelen, F., Stocker, H., Wasserman, J.D., Vegh,
M., Radimerski, T., Greenberg, M.E., and Hafen, E. (2003). The
Drosophila Forkhead transcription factor FOXO mediates the re-
duction in cell number associated with reduced insulin signaling.
J. Biol. 2, 20.
13. Puig, O., Marr, M.T., Ruhf, M.L., and Tjian, R. (2003). Control of
cell number by Drosophila FOXO: Downstream and feedback
regulation of the insulin receptor pathway. Genes Dev. 17,
2006–2020.
14. Kramer, J.M., Davidge, J.T., Lockyer, J.M., and Staveley, B.E.
(2003). Expression of Drosophila FOXO regulates growth and
can phenocopy starvation. BMC Dev. Biol. 3, 5.
15. Altomonte, J., Richter, A., Harbaran, S., Suriawinata, J., Nakae,
J., Thung, S.N., Meseck, M., Accili, D., and Dong, H. (2003). Inhi-
bition of Foxo1 function is associated with improved fasting gly-
cemia in diabetic mice. Am. J. Physiol. Endocrinol. Metab. 285,
E718–E728.
16. Puigserver, P., Rhee, J., Donovan, J., Walkey, C.J., Yoon, J.C.,
Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D.,
et al. (2003). Insulin-regulated hepatic gluconeogenesis through
FOXO1-PGC-1alpha interaction. Nature 423, 550–555.
17. Nakae, J., Biggs, W.H., III, Kitamura, T., Cavenee, W.K., Wright,
C.V., Arden, K.C., and Accili, D. (2002). Regulation of insulin ac-
tion and pancreatic beta-cell function by mutated alleles of the
gene encoding forkhead transcription factor Foxo1. Nat. Genet.
32, 245–253.
FOXO, Akt, and Infection-Induced Wasting
198518. Chan, K., Knaak, T., Satkamp, L., Humbert, O., Falkow, S., and
Ramakrishnan, L. (2002). Complex pattern of Mycobacterium
marinum gene expression during long-term granulomatous in-
fection. Proc. Natl. Acad. Sci. USA 99, 3920–3925.
19. Sarbassov, D.D., Guertin, D.A., Ali, S.M., and Sabatini, D.M.
(2005). Phosphorylation and regulation of Akt/PKB by the ric-
tor-mTOR complex. Science 307, 1098–1101.
20. Alessi, D.R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N.,
Cohen, P., and Hemmings, B.A. (1996). Mechanism of activation
of protein kinase B by insulin and IGF-1. EMBO J. 15, 6541–6551.
21. Scheid, M.P., Marignani, P.A., and Woodgett, J.R. (2002). Multi-
ple phosphoinositide 3-kinase-dependent steps in activation of
protein kinase B. Mol. Cell. Biol. 22, 6247–6260.
22. Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M., and Hem-
mings, B.A. (1995). Inhibition of glycogen synthase kinase-3 by
insulin mediated by protein kinase B. Nature 378, 785–789.
23. Miron, M., Lasko, P., and Sonenberg, N. (2003). Signaling from
Akt to FRAP/TOR targets both 4E-BP and S6K in Drosophila
melanogaster. Mol. Cell. Biol. 23, 9117–9126.
24. Lizcano, J.M., Alrubaie, S., Kieloch, A., Deak, M., Leevers, S.J.,
and Alessi, D.R. (2003). Insulin-induced Drosophila S6 kinase
activation requires phosphoinositide 3-kinase and protein ki-
nase B. Biochem. J. 374, 297–306.
25. Steppan, C.M., Wang, J., Whiteman, E.L., Birnbaum, M.J., and
Lazar, M.A. (2005). Activation of SOCS-3 by resistin. Mol. Cell.
Biol. 25, 1569–1575.
26. Lehrke, M., Reilly, M.P., Millington, S.C., Iqbal, N., Rader, D.J.,
and Lazar, M.A. (2004). An inflammatory cascade leading to
hyperresistinemia in humans. Plos Med. 1, e45 10.1371/
journal.pmed.0010045.
27. Yu, C., Chen, Y., Cline, G.W., Zhang, D., Zong, H., Wang, Y., Ber-
geron, R., Kim, J.K., Cushman, S.W., Cooney, G.J., et al. (2002).
Mechanism by which fatty acids inhibit insulin activation of insu-
lin receptor substrate-1 (IRS-1)-associated phosphatidylinositol
3-kinase activity in muscle. J. Biol. Chem. 277, 50230–50236.
28. Aguirre, V., Werner, E.D., Giraud, J., Lee, Y.H., Shoelson, S.E.,
and White, M.F. (2002). Phosphorylation of Ser307 in insulin re-
ceptor substrate-1 blocks interactions with the insulin receptor
and inhibits insulin action. J. Biol. Chem. 277, 1531–1537.
29. Rui, L., Yuan, M., Frantz, D., Shoelson, S., and White, M.F.
(2002). SOCS-1 and SOCS-3 block insulin signaling by ubiqui-
tin-mediated degradation of IRS1 and IRS2. J. Biol. Chem.
277, 42394–42398.
30. Silverman, N., Zhou, R., Erlich, R.L., Hunter, M., Bernstein, E.,
Schneider, D., and Maniatis, T. (2003). Immune activation of
NF-kappaB and JNK requires Drosophila TAK1. J. Biol. Chem.
278, 48928–48934.
31. Hirosumi, J., Tuncman, G., Chang, L., Gorgun, C.Z., Uysal, K.T.,
Maeda, K., Karin, M., and Hotamisligil, G.S. (2002). A central role
for JNK in obesity and insulin resistance. Nature 420, 333–336.
32. Wang, M.C., Bohmann, D., and Jasper, H. (2005). JNK extends
life span and limits growth by antagonizing cellular and organ-
ism-wide responses to insulin signaling. Cell 121, 115–125.
33. Etter, P.D., Narayanan, R., Navratilova, Z., Patel, C., Bohmann,
D., Jasper, H., and Ramaswami, M. (2005). Synaptic and geno-
mic responses to JNK and AP-1 signaling in Drosophila neurons.
BMC Neurosci. 6, 39.
34. Miotto, B., Sagnier, T., Berenger, H., Bohmann, D., Pradel, J.,
and Graba, Y. (2006). Chameau HAT and DRpd3 HDAC function
as antagonistic cofactors of JNK/AP-1-dependent transcription
during Drosophila metamorphosis. Genes Dev. 20, 101–112.
35. Broughton, S.J., Piper, M.D., Ikeya, T., Bass, T.M., Jacobson, J.,
Driege, Y., Martinez, P., Hafen, E., Withers, D.J., Leevers, S.J.,
et al. (2005). Longer lifespan, altered metabolism, and stress re-
sistance in Drosophila from ablation of cells making insulin-like
ligands. Proc. Natl. Acad. Sci. USA 102, 3105–3110.
36. Rulifson, E.J., Kim, S.K., and Nusse, R. (2002). Ablation of insu-
lin-producing neurons in flies: Growth and diabetic phenotypes.
Science 296, 1118–1120.
37. Gro¨nke, S., Mildner, A., Fellert, S., Tennagels, N., Petry, S.,
Mu¨ller, G., Ja¨ckle, H., and Ku¨hnlein, R.P. (2005). Brummer lipase
is an evolutionary conserved fat storage regulator in Drosophila.
Cell Metab. 1, 323–330.38. Brunet, A., Bonni, A., Zigmond, M.J., Lin, M.Z., Juo, P., Hu, L.S.,
Anderson, M.J., Arden, K.C., Blenis, J., and Greenberg, M.E.
(1999). Akt promotes cell survival by phosphorylating and inhib-
iting a Forkhead transcription factor. Cell 96, 857–868.
39. Giannakou, M.E., Goss, M., Junger, M.A., Hafen, E., Leevers,
S.J., and Partridge, L. (2004). Long-lived Drosophila with overex-
pressed dFOXO in adult fat body. Science 305, 361.
40. Hwangbo, D.S., Gersham, B., Tu, M.P., Palmer, M., and Tatar, M.
(2004). Drosophila dFOXO controls lifespan and regulates insu-
lin signalling in brain and fat body. Nature 429, 562–566.
41. Britton, J.S., Lockwood, W.K., Li, L., Cohen, S.M., and Edgar,
B.A. (2002). Drosophila’s insulin/PI3-kinase pathway coordi-
nates cellular metabolism with nutritional conditions. Dev. Cell
2, 239–249.
42. Bohni, R., Riesgo-Escovar, J., Oldham, S., Brogiolo, W.,
Stocker, H., Andruss, B.F., Beckingham, K., and Hafen, E.
(1999). Autonomous control of cell and organ size by CHICO,
a Drosophila homolog of vertebrate IRS1-4. Cell 97, 865–875.
43. Tatar, M., Kopelman, A., Epstein, D., Tu, M.P., Yin, C.M., and
Garofalo, R.S. (2001). A mutant Drosophila insulin receptor ho-
molog that extends life-span and impairs neuroendocrine func-
tion. Science 292, 107–110.
44. Shingleton, A.W., Das, J., Vinicius, L., and Stern, D.L. (2005). The
temporal requirements for insulin signaling during development
in Drosophila. PLoS Biol. 3, e289 10.1371/journal.pbio.0030289.
45. Armitage, S.A., Thompson, J.J., Rolff, J., and Siva-Jothy, M.T.
(2003). Examining costs of induced and constitutive immune in-
vestment in Tenebrio molitor. J. Evol. Biol. 16, 1038–1044.
46. Derting, T.L., and Compton, S. (2003). Immune response, not im-
mune maintenance, is energetically costly in wild white-footed
mice (Peromyscus leucopus). Physiol. Biochem. Zool. 76, 744–
752.
47. Ksiazek, A., Konarzewski, M., Chadzinska, M., and Cichon, M.
(2003). Costs of immune response in cold-stressed laboratory
mice selected for high and low basal metabolism rates. Proc.
Biol. Sci. 270, 2025–2031.
48. Ahmed, A.M., Baggott, S.L., Maingon, R., and Hurd, H. (2002).
The costs of mounting an immune response are reflected in
the reproductive fitness of the mosquito Anopheles gambiae.
Oikos 97, 371–377.
49. Moret, Y., and Schmid-Hempel, P. (2000). Survival for immunity:
The price of immune system activation for bumblebee workers.
Science 290, 1166–1168.
50. McKean, K.A., and Nunney, L. (2001). Increased sexual activity
reduces male immune function in Drosophila melanogaster.
Proc. Natl. Acad. Sci. USA 98, 7904–7909.
51. Siva-Jothy, M.T., Tsubaki, Y., and Hooper, R.E. (1998). De-
creased immune response as a proximate cost of copulation
and oviposition in a damselfly. Physiol. Entomol. 23, 274–277.
52. Powanda, M.C., and Beisel, W.R. (2003). Metabolic effects of in-
fection on protein and energy status. J. Nutr. 133, 322S–327S.
53. Basoglu, O.K., Bacakoglu, F., Cok, G., Sayiner, A., and Ates, M.
(1999). The oral glucose tolerance test in patients with respira-
tory infections. Monaldi Arch. Chest Dis. 54, 307–310.
54. Oluboyo, P.O., and Erasmus, R.T. (1990). The significance of glu-
cose intolerance in pulmonary tuberculosis. Tubercle 71, 135–
138.
55. Andersen, S.K., Gjedsted, J., Christiansen, C., and Tonnesen, E.
(2004). The roles of insulin and hyperglycemia in sepsis patho-
genesis. J. Leukoc. Biol. 75, 413–421.
56. Van den Berghe, G. (2000). Novel insights into the neuroendocri-
nology of critical illness. Eur. J. Endocrinol. 143, 1–13.
57. Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C.,
Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P.,
Lauwers, P., and Bouillon, R. (2001). Intensive insulin therapy
in the critically ill patients. N. Engl. J. Med. 345, 1359–1367.
